Novanta (NASDAQ:NOVT) Hits New 1-Year Low – Should You Sell?

Novanta Inc. (NASDAQ:NOVTGet Free Report)’s share price reached a new 52-week low during mid-day trading on Tuesday . The company traded as low as $140.53 and last traded at $143.43, with a volume of 12456 shares. The stock had previously closed at $143.17.

Analysts Set New Price Targets

Separately, Robert W. Baird dropped their target price on shares of Novanta from $175.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, November 6th.

Get Our Latest Report on NOVT

Novanta Stock Performance

The firm’s 50-day moving average price is $151.14 and its two-hundred day moving average price is $165.54. The company has a debt-to-equity ratio of 0.61, a quick ratio of 1.81 and a current ratio of 2.79. The stock has a market cap of $5.13 billion, a price-to-earnings ratio of 85.51 and a beta of 1.28.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the company. Sanctuary Advisors LLC acquired a new position in shares of Novanta during the 3rd quarter valued at about $232,000. KBC Group NV lifted its position in Novanta by 41.6% in the fourth quarter. KBC Group NV now owns 1,500 shares of the technology company’s stock valued at $229,000 after buying an additional 441 shares during the last quarter. Exchange Traded Concepts LLC lifted its position in Novanta by 4.0% in the fourth quarter. Exchange Traded Concepts LLC now owns 120,566 shares of the technology company’s stock valued at $18,419,000 after buying an additional 4,648 shares during the last quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC lifted its position in Novanta by 110.2% in the third quarter. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC now owns 100,259 shares of the technology company’s stock valued at $17,938,000 after buying an additional 52,573 shares during the last quarter. Finally, Charles Schwab Investment Management Inc. lifted its position in Novanta by 1.0% in the third quarter. Charles Schwab Investment Management Inc. now owns 439,390 shares of the technology company’s stock valued at $78,616,000 after buying an additional 4,271 shares during the last quarter. Institutional investors and hedge funds own 98.35% of the company’s stock.

Novanta Company Profile

(Get Free Report)

Novanta, Inc engages in the provision of core technology solutions to healthcare and advanced industrial original equipment manufacturers. It operates through the following segments: Photonics, Vision, and Precision Motion. The Photonics segment designs, manufactures, and markets photonics-based solutions, including laser scanning and laser beam delivery, CO2 laser, continuous wave and ultrafast laser, and optical light engine products.

Featured Articles

Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.